Monovo (Mometasone Furoate)

Mometasone furoate, the active ingredient in Monovo, is a corticosteroid presented as a topical formulation for skin use. It reduces inflammation and itching in various dermatologic conditions.\n\nGNH India supplies Monovo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a topical corticosteroid used to manage inflammatory skin disorders.\n\n- Atopic dermatitis: reduces redness, swelling, and itching associated with eczema.\n- Psoriasis: diminishes plaque formation and scaling.\n- Contact dermatitis: alleviates irritation caused by allergic reactions to external substances.\n- Seborrheic dermatitis: controls flaking and inflammation on scalp and face.

Mometasone furoate may cause local and systemic adverse reactions when applied to the skin.\n\nCommon Side Effects:\n- Burning or stinging sensation at the application site.\n- Pruritus or mild itching.\n- Dryness or flaking of the skin.\n- Acne‑like eruptions (folliculitis).\n\nSerious or Rare Side Effects:\n- Skin atrophy or thinning with prolonged use.\n- Hypopigmentation or depigmentation of treated areas.\n- Allergic contact dermatitis or severe rash.\n- Secondary bacterial, fungal or viral infection.\n- Systemic adrenal suppression when large areas are treated extensively.

When using topical mometasone furoate, consider the following safety measures.\n\n- Avoid use on infected or broken skin: may worsen infection.\n- Limit duration of therapy: prolonged use increases risk of skin atrophy.\n- Use the lowest effective potency: reduces likelihood of adverse effects.\n- Do not apply occlusive dressings unless directed: can enhance systemic absorption.\n- Caution in children: higher surface‑area‑to‑body‑mass ratio raises systemic exposure risk.\n- Store at room temperature: keep in the original container, protect from moisture and light.

Topical mometasone furoate can interact with other medications, affecting safety or efficacy.\n\nMajor Interactions (Avoid):\n- Systemic corticosteroids: additive glucocorticoid effects may lead to systemic side effects.\n- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic absorption of mometasone.\n- Topical antifungal agents applied to the same area: risk of local irritation.\n\nModerate Interactions (Monitor Closely):\n- Topical calcineurin inhibitors (e.g., tacrolimus): potential additive immunosuppression.\n- Phototherapy (UVB/UVA): may increase skin sensitivity and risk of burns.\n- Live vaccines: systemic absorption could theoretically diminish vaccine response.